Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded as low as $26.01 and last traded at $26.01, with a volume of 20114 shares changing hands. The stock had previously closed at $30.50.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on OPCH shares. Barrington Research restated an "outperform" rating and issued a $40.00 price objective on shares of Option Care Health in a research report on Wednesday, October 23rd. JMP Securities boosted their price target on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Finally, Bank of America cut Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $43.00 to $29.00 in a report on Wednesday.
Check Out Our Latest Research Report on OPCH
Option Care Health Price Performance
The company has a market cap of $4.03 billion, a PE ratio of 20.21, a PEG ratio of 2.31 and a beta of 1.29. The firm's 50-day moving average is $30.96 and its 200-day moving average is $30.06. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating analysts' consensus estimates of $0.27 by $0.03. The company had revenue of $1.23 billion during the quarter, compared to analysts' expectations of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The firm's revenue for the quarter was up 14.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.63 EPS. On average, equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.
Insider Activity
In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business's stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares of the company's stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business's stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company's stock, valued at $663,429.51. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.64% of the company's stock.
Institutional Investors Weigh In On Option Care Health
Large investors have recently bought and sold shares of the business. Park Place Capital Corp boosted its holdings in shares of Option Care Health by 48.4% during the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company's stock valued at $38,000 after acquiring an additional 372 shares during the last quarter. Blue Trust Inc. grew its position in Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock worth $81,000 after purchasing an additional 377 shares during the period. GAMMA Investing LLC raised its stake in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after buying an additional 471 shares during the last quarter. Trust Point Inc. lifted its holdings in shares of Option Care Health by 2.6% during the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company's stock valued at $755,000 after buying an additional 622 shares during the period. Finally, Nisa Investment Advisors LLC boosted its stake in shares of Option Care Health by 5.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company's stock worth $376,000 after buying an additional 690 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.
About Option Care Health
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.